Search research articles
Contact Us
Filters
Showing results (271-280 of 386) with videos related to
Page
of 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics
Michael A Carducci, Joel B Nelson, M Kathy Bowling, et al.
European Urology Oncology
|
August 19, 2020
Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial
Alan H Bryce, Yu Hui Chen, Glenn Liu, et al.
Cancers
|
June 2, 2021
Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
Joeri A J Douma, Laurien M Buffart, Ramy Sedhom, et al.
JAMA Oncology
|
February 14, 2020
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Jason W D Hearn, Christopher J Sweeney, Nima Almassi, et al.
European Urology
|
June 10, 2019
Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer
Pedro Isaacsson Velho, Wei Fu, Hao Wang, et al.
Clinical Pharmacology and Therapeutics
|
May 30, 2008
Pharmacogenetic pathway analysis of docetaxel elimination
S D Baker, J Verweij, G A Cusatis, et al.
American Journal of Cancer Therapy and Pharmacology
|
January 13, 2015
A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA
Jianqing Lin, Tingting Zhan, Danielle Duffy, et al.
JCO Precision Oncology
|
October 26, 2019
Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical Prostatectomy
Pedro Isaacsson Velho, David Lim, Hao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2017
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, et al.
The Oncologist
|
April 22, 2025
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes
Yasaman Iranmanesh, Noha Omar, Arya Rasouli, et al.
Page
of 39
Search research articles
Search
Showing results (271-280 of 386) with videos related to
Sort By:
Page
of 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics
Michael A Carducci, Joel B Nelson, M Kathy Bowling, et al.
European Urology Oncology
|
August 19, 2020
Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial
Alan H Bryce, Yu Hui Chen, Glenn Liu, et al.
Cancers
|
June 2, 2021
Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
Joeri A J Douma, Laurien M Buffart, Ramy Sedhom, et al.
JAMA Oncology
|
February 14, 2020
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Jason W D Hearn, Christopher J Sweeney, Nima Almassi, et al.
European Urology
|
June 10, 2019
Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer
Pedro Isaacsson Velho, Wei Fu, Hao Wang, et al.
Clinical Pharmacology and Therapeutics
|
May 30, 2008
Pharmacogenetic pathway analysis of docetaxel elimination
S D Baker, J Verweij, G A Cusatis, et al.
American Journal of Cancer Therapy and Pharmacology
|
January 13, 2015
A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA
Jianqing Lin, Tingting Zhan, Danielle Duffy, et al.
JCO Precision Oncology
|
October 26, 2019
Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical Prostatectomy
Pedro Isaacsson Velho, David Lim, Hao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2017
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, et al.
The Oncologist
|
April 22, 2025
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes
Yasaman Iranmanesh, Noha Omar, Arya Rasouli, et al.
Page
of 39